how do glp 1 reduce inflammation Mechanisms by which GLP-1 agonists may exert beneficial effects on the Anti-inflammatory properties of GLP-1 receptor

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)

This can be used alongside GLP-1 medications to manage blood sugar levels and weight

Mounjaro, 5 months Finally understand what normal eating feels like

Whilst these medications offer substantial metabolic benefits, their use has raised questions about potential adverse effects, including impacts on gallbladder health